Oragenics, Inc. (LON:0A64)

Oragenics Statistics

Total Valuation

Oragenics has a market cap or net worth of GBP 2.02 million. The enterprise value is -6.06 million.

Market Cap	2.02M
Enterprise Value	-6.06M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	715,771
Shares Outstanding	n/a
Shares Change (YoY)	+1,588.05%
Shares Change (QoQ)	+113.29%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	2.22%
Float	3.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.28
P/TBV Ratio	0.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.75
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.04.

Current Ratio	4.42
Quick Ratio	3.97
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.95

Financial Efficiency

Return on equity (ROE) is -168.95% and return on invested capital (ROIC) is -92.41%.

Return on Equity (ROE)	-168.95%
Return on Assets (ROA)	-71.33%
Return on Invested Capital (ROIC)	-92.41%
Return on Capital Employed (ROCE)	-103.95%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-2.03M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-91.94%
50-Day Moving Average	6.62
200-Day Moving Average	18.44
Relative Strength Index (RSI)	45.77
Average Volume (20 Days)	2,415

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.49

Income Statement

Revenue	n/a
Gross Profit	-2.52M
Operating Income	-7.60M
Pretax Income	-8.11M
Net Income	-8.11M
EBITDA	n/a
EBIT	-7.60M
Earnings Per Share (EPS)	-6.41

Balance Sheet

The company has 8.48 million in cash and 293,734 in debt, with a net cash position of 8.19 million.

Cash & Cash Equivalents	8.48M
Total Debt	293,734
Net Cash	8.19M
Net Cash Per Share	n/a
Equity (Book Value)	7.31M
Book Value Per Share	1.77
Working Capital	7.31M

Cash Flow

Operating Cash Flow	-6.27M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oragenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,588.05%
Shareholder Yield	-1,588.05%
Earnings Yield	-401.70%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 23, 2023. It was a reverse split with a ratio of 0.0166666667.

Last Split Date	Jan 23, 2023
Split Type	Reverse
Split Ratio	0.0166666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	2